Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Resolvis Omega
- Development stage
- Phase 1
- Lead developer
- Medivis
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
Resolvis (specifically Resolvis Omega) is an ophthalmic emulsion developed by Medivis for the treatment of dry eye disease and other ocular surface conditions. The formulation contains omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are designed to integrate into and stabilize the lipid layer of the tear film. This action reduces tear evaporation and provides a protective barrier on the ocular surface. Additionally, these omega-3 fatty acids serve as precursors to specialized pro-resolving mediators (SPMs) like resolvins, which help modulate the inflammatory response associated with chronic dry eye. The product is typically administered as topical eye drops and is often regulated as a medical device in European markets.
- Brand names
- ResolvisResolvis Omega
02
Targets
FFAR4 (Free fatty acid receptor 4)
Beyond the preview
Go deeper on Resolvis Omega.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Resolvis Omega.